Erectile Dysfunction Drugs
Drug Recalls information center:
Viagra® and Cialis®
Viagra® was approved by the FDA in March of 1998 for the treatment of erectile dysfunction (ED) and has since been prescribed to millions of men in the U.S. and around the world. Two months after approval, Pfizer™ issued a letter warning of sudden drops in systemic blood pressure in a majority of patients taking Viagra®. Doctors were advised to take their patients’ cardiac status into account before prescribing the drug.
In November of 1998, new product warning labels were placed on Viagra® bottles in response to the potential dangers associated with its use. Viagra’s® new warning labels mentioned the possibility of heart attack, sudden death due to cardiac complications, hypertension, and priapism, a serious disorder requiring immediate medical attention in which a man develops a painful and prolonged erection.
Side effects are not limited to cardiovascular complications alone. A study completed in January 2006 suggested that men with a history of high blood pressure and heart attack who take Viagra® or Cialis® are ten times more likely to suffer from a vision threatening condition called NAION. Prior to this report, the Journal of Neuro-Opthalmology published the results of a study in which seven men experienced NAION within three days of taking Viagra® and other ED medications. According to a subsequent CBS News report, over 8,000 ED patients claimed to have experienced vision problems while taking Viagra®, Cialis® or other related medications.
If you have been adversely affected by Viagra® or Cialis®, you may be eligible to receive compensation for your damages. Call our Law Firm we can help.
We are committed to our clients. If you or a family member has suffered a loss - call us day or night at 1-888-513-6198 or locally at 210-922-2200
|